Long-term functional follow-up of pediatric extremity sarcoma patients treated with brachytherapy

doi:10.5312/wjo.122034

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

(8)

(7)

(0)

(70)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Orthopedics

ISSN

2218-5836

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Orthop. Aug 18, 2026; 17(8): 122034
Published online Aug 18, 2026. doi: 10.5312/wjo.122034

Full Size Figure Download Figure

Figure 1 Patient A. A-C: Perioperative pictures and dose plan; D: Left lower arm, extra-osseous Ewing’s sarcoma, 5 years post-op (dorsal cotton swab due to recent blood draw).

Citation: Kveller C, Safwat A, Lindegaard JC, Bendtsen MM, Baad-Hansen T. Long-term functional follow-up of pediatric extremity sarcoma patients treated with brachytherapy. World J Orthop 2026; 17(8): 122034
URL: https://www.wjgnet.com/2218-5836/full/v17/i8/122034.htm
DOI: https://dx.doi.org/10.5312/wjo.122034

Kveller C, Safwat A, Lindegaard JC, Bendtsen MM, Baad-Hansen T. Long-term functional follow-up of pediatric extremity sarcoma patients treated with brachytherapy. World J Orthop 2026; 17(8): 122034 [DOI: 10.5312/wjo.122034]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.